Similar articles for PMID: 32887768

Year	Number of Results
1996	1
1997	1
1998	2
1999	6
2000	1
2001	5
2002	5
2003	3
2004	6
2005	6
2006	2
2007	1
2008	2
2009	3
2010	2
2011	4
2012	3
2013	5
2014	6
2015	10
2016	8
2017	4
2018	4
2019	10
2020	7
2021	1
2022	0

1

Lymphoscintigraphic Mapping in Melanoma and Breast Cancer.

Young MA. Young MA. J Nucl Med Technol. 2020 Dec;48(4):311-314. doi: 10.2967/jnmt.120.246918. Epub 2020 Sep 4. J Nucl Med Technol. 2020. PMID: 32887768 Free article. Review.

2

[Contribution of nuclear medicine to lymphatic mapping and sentinel node identification in oncology].

Valdés Olmos RA, Jansen L, Muller SH, Hoefnagel CA, Nieweg O. Valdés Olmos RA, et al. Rev Esp Med Nucl. 1999;18(2):111-21. Rev Esp Med Nucl. 1999. PMID: 10352326 Review. Spanish.

3

Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma.

Glass EC, Essner R, Morton DL. Glass EC, et al. J Nucl Med. 1998 Jul;39(7):1185-90. J Nucl Med. 1998. PMID: 9669391 Free article. Clinical Trial.

4

Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers.

Alazraki NP, Eshima D, Eshima LA, Herda SC, Murray DR, Vansant JP, Taylor AT. Alazraki NP, et al. Semin Nucl Med. 1997 Jan;27(1):55-67. doi: 10.1016/s0001-2998(97)80036-0. Semin Nucl Med. 1997. PMID: 9122724 Review.

5

[Lymphoscintigraphy in oncology--the role in the preoperative diagnosis].

Zaorska-Rajca J, Chrapko B, Cholewiński W. Zaorska-Rajca J, et al. Wiad Lek. 2005;58(9-10):561-6. Wiad Lek. 2005. PMID: 16529071 Review. Polish.

6

Lymphoscintigraphy with peritumoral injection versus lymphoscintigraphy with subdermal periareolar injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.

Caruso G, Cipolla C, Costa R, Morabito A, Latteri S, Fricano S, Salerno S, Latteri MA. Caruso G, et al. Acta Radiol. 2014 Feb;55(1):39-44. doi: 10.1177/0284185113493775. Epub 2013 Aug 7. Acta Radiol. 2014. PMID: 23926236 Free article.

7

Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.

Gherghe M, Bordea C, Blidaru A. Gherghe M, et al. Chirurgia (Bucur). 2015 Jan-Feb;110(1):26-32. Chirurgia (Bucur). 2015. PMID: 25800312 Free article.

8

Indocyanine Green Fluorescence Imaging with Lymphoscintigraphy for Sentinel Node Biopsy in Melanoma: Increasing the Sentinel Lymph Node-Positive Rate.

Knackstedt R, Couto RA, Ko J, Cakmakoglu C, Wu D, Gastman B. Knackstedt R, et al. Ann Surg Oncol. 2019 Oct;26(11):3550-3560. doi: 10.1245/s10434-019-07617-z. Epub 2019 Jul 16. Ann Surg Oncol. 2019. PMID: 31313036

9

Desirable Properties of Radiopharmaceuticals for Sentinel Node Mapping in Patients With Breast Cancer Given the Paradigm Shift in Patient Management.

Kim CK, Zukotynski KA. Kim CK, et al. Clin Nucl Med. 2017 Apr;42(4):275-279. doi: 10.1097/RLU.0000000000001565. Clin Nucl Med. 2017. PMID: 28166148 Review.

10

Same-day or next-day sentinel node biopsy after lymphoscintigraphy for melanoma using ^99m Tc-labelled antimony sulphide colloid.

Thompson JF, London K, Uren RF, Pennington TE, Saw RPM, Lo SN. Thompson JF, et al. Br J Surg. 2020 Dec;107(13):1773-1779. doi: 10.1002/bjs.11844. Epub 2020 Aug 21. Br J Surg. 2020. PMID: 32820818 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed